0+
Attendees Representing Vaccine Manufacturers, Institutes, Regulators
0+
Companies From India, China, Africa, Brazil, and More!
0+
Speakers Sharing Their Expertise
0+
In-Person Networking Hours
0+
Case Studies
The Concept
Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is worth USD 41.4 Billion in 2021 and is estimated to reach USD 67.2 Billion in 2026 at a CAGR of 10.2% from 2021 to 2026. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs.
The economies of developing countries, for example, India is growing at a tremendous speed, and it is expected to grow 18% within the next decade to about USD 3 Billion by 2026. Emerging manufacturers play a critical role in the supply of vaccines of developing countries, particularly basic and some combination vaccines. 30% of UNICEF’s total procurement comes from emerging manufacturers. The decrease in vaccine prices can also be attributed to increased competition and higher production capacities for individual vaccines brought about by the entry of emerging market manufacturers, particularly in the underused vaccines market.
Vaccines World Summit 2024, for Developing Economies, aims to bring together key experts and decision-makers from vaccine manufacturers, governmental organizations, regulators, non-profit organizations, and solution providers together to aid in advancements in this industry with significantly higher collaboration.
Vaccine World Summit 2024 speakers
Great Indian Biologics Festival 2024
2024 Agenda At A Glance
Vaccination programs save millions of lives each year globally. With more than 100 million children immunized each year, global immunization coverage has never been higher. Sources indicate that the worldwide market for vaccines is expected to reach USD 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3% from 2016 to 2021. The key drivers driving the growth of this market are a high prevalence of diseases, rising government and nongovernment funding for vaccine development, increasing investments by companies, and increasing focus on immunization programs. With factors such as advances in immunology, genetics, and vaccine technology as well as increased demand from population growth in emerging economies, the global vaccine market is expected to surpass an estimated USD 100 billion by 2025. The economies of developing countries, for example, India is growing at a tremendous speed, and it is expected to grow 10-15% within the next decade. Emerging manufacturers play a critical role in the supply of vaccines of developing countries, particularly basic and some combination vaccines. 30% of UNICEF’s total procurement comes from emerging manufacturers. The decrease in vaccine prices can also be attributed to increased competition and higher production capacities for individual vaccines brought about by the entry of emerging market manufacturers, particularly in the underused vaccines market. Vaccines World Summit, for developing economies, aims to bring together key experts and decision-makers from vaccine manufacturers, governmental organizations, regulators, non-profit organizations, and solution providers together to aid in advancements in this industry with significantly higher collaboration.
Leadership Panel - Exploring Partnerships in Developing & Manufacturing Vaccines in the International Sector
Futureproofing Pandemics & Creating Resilience in Developing Economies
New System Approaches in Designing Next Generation Vaccines in Developing Economies Vaccines for Emerging Infectious Diseases in Developing Economies
Clinical Trial Case Studies of Next- Gen & New Vaccines from South Asia
Effective Strategies to Produce and Manufacture Vaccines at Scale and Pace
Vaccine Tech Transfer
Cold Chain Management for Vaccines
Last Mile Distribution Challenges- Case Studies from Developing Economies
2024 Sponsors
Gold Sponsor
Associate Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Advertiser
Limited Special - End User
SGD 1695/-
- 2- Day Conference Access
- Valid until 22nd September 2023
- Standard Rate: SGD 2705/-
Limited Special - Solution Providers
SGD 4060/--
- 2- Day Conference Access
- Valid until 22nd September 2023
- Standard Rate: SGD 4603/-
Event Materials
Infographic: Impact on Global Health
India Cell & Gene Therapy Insights
1
Thought Leadership
Present your expertise to the key vaccines stakeholders from developing economies through a variety of available speaking packages.
2
Exhibit
Join the exhibition, and build an impressive presence among your potential clients.
3
Branding
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
4
Networking
Engage with and build lasting connections that matter the most to your business.
5
Lead Generation
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.
#VWS Experience Shared
It's my pleasure to be a participant in IMAPAC's 11th World Vaccine Summit. This virtual platform supported in exploring more on the current trends on vaccine developments from various manufacturers/ research centters
BravoVax
China
Excellent event with with good knowledge-sharing by experienced scientists globally to combat present situation and challenges faced by the vaccines manufacturing industry. Kind hospitality by IMAPAC...Keep it up.
Hester Biosciences Limited
India
Talks were very interesting addressing subjects really important such as the balance of Th1 and Th2 cells as immune response of COVID-19 vaccines. I watched a lot watching and rewatching the videos too.
Instituto Butantan
Brazil
Other Related Events
